ERBB2 and breast carcinoma: Since Brk signals downstream of the EGFR [20,21,30,30] and HER2 [29] tyrosine kinases, the EGFR/HER2-overexpressing SKBr3 breast cancer cell line and the EGFR-overexpressing BT-20 breast cancer cell line were chosen for these studies.